Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

CUSIP: 50127T109

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,054,674
Total 13F shares
32,044,753
Share change
-436,388
Total reported value
$531,121,734
Price per share
$16.59
Number of holders
100
Value change
-$3,584,064
Number of buys
46
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2019

As of 31 Mar 2019, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,044,753 shares. The largest 10 holders included EcoR1 Capital, LLC, GREAT POINT PARTNERS LLC, BVF INC/IL, BlackRock Inc., EAGLE ASSET MANAGEMENT INC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, ARCH VENTURE CORP, and CARILLON TOWER ADVISERS, INC.. This page lists 100 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.